Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Plasminogen Activator, Urokinase (PLAU) (C-Term) Peptide

PLAU Reactivité: Humain Hôte: Synthetic BP, WB
N° du produit ABIN981838
  • Antigène Tous les produits PLAU
    PLAU (Plasminogen Activator, Urokinase (PLAU))
    Protein Region
    C-Term
    Origine
    Humain
    Source
    • 1
    Synthetic
    Application
    Blocking Peptide (BP), Western Blotting (WB)
    Séquence
    CSLQGRMTLT GIVSWGRGCA LKDKPGVYTR VSHFLPWIRS HTKEENGLAL
    Attributs du produit
    This is a synthetic peptide designed for use in combination with anti-PLAU Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
    Purification
    Purified
  • Indications d'application
    Each Investigator should determine their own optimal working dilution for specific applications.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
    Concentration
    1 mg/mL
    Buffer
    Final peptide concentration is 1 mg/mL in PBS.
    Conseil sur la manipulation
    Avoid repeated freeze-thaw cycles.
    Stock
    -20 °C
    Stockage commentaire
    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Antigène
    PLAU (Plasminogen Activator, Urokinase (PLAU))
    Synonymes
    PLAU Peptide, u-PA Peptide, ATF Peptide, BDPLT5 Peptide, QPD Peptide, UPA Peptide, URK Peptide, uPA Peptide, UPAM Peptide, plasminogen activator, urokinase Peptide, urokinase-type plasminogen activator Peptide, PLAU Peptide, CpipJ_CPIJ002131 Peptide, CpipJ_CPIJ006543 Peptide, CpipJ_CPIJ013396 Peptide, CpipJ_CPIJ013623 Peptide, Plau Peptide
    Sujet
    This gene encodes a serine protease involved in degradation of the extracellular matrix and possibly tumor cell migration and proliferation. A specific polymorphism in this gene may be associated with late-onset Alzheimer's disease and also with decreased affinity for fibrin-binding. This protein converts plasminogen to plasmin by specific cleavage of an Arg-Val bond in plasminogen. Plasmin in turn cleaves this protein at a Lys-Ile bond to form a two-chain derivative in which a single disulfide bond connects the amino-terminal A-chain to the catalytically active, carboxy-terminal B-chain. This two-chain derivative is also called HMW-uPA (high molecular weight uPA). HMW-uPA can be further processed into LMW-uPA (low molecular weight uPA) by cleavage of chain A into a short chain A (A1) and an amino-terminal fragment. LMW-uPA is proteolytically active but does not bind to the uPA receptor.

    Alias Symbols: ATF, UPA, URK, u-PA, QPD, BDPLT5

    Protein Interaction Partner: CTSB,CTSL1,F2,HGF,IGF2R,LRP2,NID1,PLAT,PLAUR,PLG,SERPINA5,SERPINB2,SERPINB6,SERPINE1,SERPINF2,ST14,HRAS,LRP2,MAP2K1,PLAT,PLAUR,SERPINA5,SERPINB2,SERPINE1,SERPINE2

    Protein Size: 431
    Poids moléculaire
    28 kDa
    ID gène
    5328
    NCBI Accession
    NM_002658, NP_002649
    UniProt
    P00749
Vous êtes ici:
Support technique